Related Experiment Video
Updated: Oct 25, 2025

05:32
Author Spotlight: Characterizing DNA G-Quadruplex by Bis-3-Chloropiperidine Based Chemical Mapping
Published on: May 12, 2023
1.6K
An Oligo-Library-Based Approach for Mapping DNA-DNA Triplex Interactions In Vitro
Beate Kaufmann1, Or Willinger1, Nanami Kikuchi1
1Department of Biotechnology and Food Engineering, Technion - Israel Institute of Technology, Haifa 32000, Israel.
ACS Synthetic Biology
|August 10, 2021
Summary
Triplex-seq, a deep-sequencing method, maps DNA triplex interactions. It identifies key DNA triplex-forming motifs (TFMs) and reveals sequence and pH-dependent binding rules for enhanced DNA triplex code understanding.
Area of Science:
- Molecular Biology
- Genomics
- Biochemistry
Background:
- DNA triplexes are crucial for gene regulation and therapeutic applications.
- Understanding the sequence and environmental factors governing triplex formation is essential.
Purpose of the Study:
- To develop and validate a deep-sequencing method (Triplex-seq) for systematically mapping DNA triplex interactions.
- To identify sequence motifs and conditions that dictate triplex formation and stability.
Main Methods:
- Utilized a large library of single-stranded DNA triplex-forming oligos (TFOs) against various double-stranded DNA triplex target sites (TTSs).
- Employed deep sequencing to analyze millions of TFO variants under different pH conditions (pH 5 and pH 7).
- Applied information analysis to identify minimal functional TFO sequences (triplex-forming motifs, TFMs).
Main Results:
- Identified G-rich triplexes forming at both pH 5 and pH 7, with higher stability at pH 5.
- Discovered a subset of TFOs forming triplexes exclusively at pH 5.
- Validated TFMs, demonstrating their role in G-rich TTS binding and the impact of single mutations on binding affinity.
Conclusions:
- Deep sequencing significantly enhances the understanding of DNA triplex binding rules.
- The findings aid in refining the DNA triplex code for potential applications in synthetic biology and therapeutics.

